Any feedback?
Literature summary for 3.5.3.18 extracted from
- Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: a basis for the design of specific inhibitors (2006), Structure, 14, 901-911.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | structure-based development of specific DDAH-1 inhibitors that might be useful in the therapeutic treatment of NOS dysfunction-related diseases | Bos taurus |
Crystallization (Commentary)
| Crystallization (Comment) | Organism |
|---|---|
| by sitting drop vapor diffusion, at 1.08-2.0 A resolution and at pH 6.3 and pH 9.0 | Bos taurus |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| L-citrulline | - |
Bos taurus |  |
| L-homocysteine | - |
Bos taurus | |
| S-nitroso-L-homocysteine | - |
Bos taurus | |
| Zn2+ | - |
Bos taurus | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Bos taurus | P56965 | - |
- |
Purification (Commentary)
| Purification (Comment) | Organism |
|---|---|
| anion exchange chromatography and gel filtration chromatography | Bos taurus |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| brain | - |
Bos taurus | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| DDAH-1 | - |
Bos taurus |
| dimethylarginine dimethylaminohydrolase | - |
Bos taurus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
